{
    "code": "72000016",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=72000016",
    "time": "2020-12-25 05:08:07",
    "許可證字號": "衛部罕菌疫輸字第000016號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/12\/15",
    "發證日期": "105\/12\/15",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA07200001606",
    "中文品名": "舒立瑞 濃縮靜脈輸注液 300毫克",
    "英文品名": "Soliris 300 mg concentrate for solution for infusion",
    "適應症": "1. 治療陣發性夜間血紅素尿症(PNH)病人。說明：Soliris治療需要輸血或曾有血栓併發症的病人。\r\n2. 治療對血漿治療反應不佳之非典型溶血性尿毒症候群(aHUS)病人。說明：過去一星期內接受至少4次血漿治療後血小板計數低於正常值的病人。\r\n使用限制：舒立瑞不可以用於治療Shiga toxin E. coli相關的溶血性尿毒症候群的病人。",
    "劑型": "27D注射液劑",
    "包裝": "30毫升玻璃小瓶裝 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "110\/12\/15",
    "主成分略述": "Eculizumab",
    "限制項目": "02輸　入 1D須執行風險管理計畫",
    "申請商名稱": "620118D857  台灣大昌華嘉股份有限公司",
    "申請商地址": "台北市內湖區堤頂大道二段407巷20弄1、3、5、7號10樓及22、24、26號10樓及22號10樓之1",
    "主製造廠": [
        {
            "製造廠名稱": "FIE0101100  Alexion Pharma International Operations Unlimited Company",
            "製造廠廠址": "Monksland Industrial Estate, Athlone, Roscommon, Ireland",
            "製造廠公司地址": "",
            "製造廠國別": "IRELAND",
            "製程": ""
        },
        {
            "製造廠名稱": "FIT9099000  PATHEON ITALIA S.P.A.",
            "製造廠廠址": "VIALE G.B. STUCCHI, 110-20900 MONZA (MB), ITALY",
            "製造廠公司地址": "",
            "製造廠國別": "ITALY",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FES0214000  Lonza Biologics Porrino, S.L.",
            "製造廠廠址": "A Relva s\/n 36400 O Porrino Pontevedra, Spain",
            "製造廠公司地址": "",
            "製造廠國別": "SPAIN",
            "製程": "原料藥製造廠"
        },
        {
            "製造廠名稱": "FIE0107000  Alexion Pharma International Operations Unlimited Company (APIOUC)",
            "製造廠廠址": "College Business and Technology Park, Blanchardstown Road North, Dublin15, Ireland",
            "製造廠公司地址": "",
            "製造廠國別": "IRELAND",
            "製程": "二級包裝廠"
        },
        {
            "製造廠名稱": "FSG0032000  Lonza Biologics Tuas Pte Ltd.",
            "製造廠廠址": "35 Tuas South Avenue 6, Singapore, 637377",
            "製造廠公司地址": "",
            "製造廠國別": "SINGAPORE",
            "製程": "原料藥製造廠"
        },
        {
            "製造廠名稱": "FUS1053000  ALEXION RHODE ISLAND MANUFACTURING FACILITY",
            "製造廠廠址": "100 TECHNOLOGY WAY, SMITHFIELD, RHODE ISLAND 02917, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "原料藥製造廠"
        }
    ],
    "CCC號列": "30021500005 免疫產品，具有劑量或零售包裝式樣者Immunological products, put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200082500",
            "成分名稱": "Eculizumab",
            "含量描述": "",
            "含量": "10.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "SOL TW leaflet-TW04_700992_P5 (20DEC)-108-05-06.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=72000016&Seq=012&Type=9"
        },
        {
            "title": "220000160001-106-02-24.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=72000016&Seq=001&Type=9"
        },
        {
            "title": "SOL TW ctn 700993_P1_AAMF (16Nov2018)-109-07-09(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=72000016&Seq=005&Type=8"
        },
        {
            "title": "Carton_000016 201711-107-03-19(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=72000016&Seq=004&Type=8"
        },
        {
            "title": "220000160002-106-02-24.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=72000016&Seq=001&Type=8"
        }
    ]
}